Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The Dr Stanley Ho Medical Development Foundation will continue its funding support for The Centre for Personalised Medicine (CPM) for further seven years.

A signing ceremony took place in February to mark this funding agreement. Professor Anneke Lucassen, Professor of Genomic Medicine at the Nuffield Department of Medicine, Director of the Centre for Personalised Medicine; Ian Huen, Trustee Dr Stanley Ho Medical Development Foundation, Dame Mary Archer, Chancellor of the University of Buckingham, Chair of External Advisory Board CPM, Helen King, Principal of St Anne's College and Professor John Todd, Director of the Wellcome Centre for Human Genetics, attended the signing ceremony.

The Centre for Personalised Medicine was established through a very generous donation from the Dr Stanley Ho Medical Development Foundation to St Anne’s College in 2013. The Centre serves as a platform for students, academics, clinicians, the public, and policy makers to delve into the advantages and challenges associated with personalised medicine. Throughout the academic year, the Centre organizes a wide range of engagement events, from intimate lectures and seminars at individual colleges to larger conferences, public talks, and international symposia.

Personalised medicine refers to the utilization of measurable data about an individual to guide their healthcare, rather than treating a group or population uniformly. With the advancement of technology, we are now able to generate a significant amount of health-related information about individuals.

Professor Anneke Lucassen said: “I am so delighted that the Centre for Personalised Medicine has received a generous 7 year funding award. This will allow us to research, debate, engage and implement a range of personalised medicine approaches so that developments in technology and data analysis can be translated into improved healthcare”.

Similar stories

Benemérita Universidad Autónoma de Puebla representatives visit Jenner Institute

Academic representatives from Benemérita Universidad Autónoma de Puebla (BUAP), one of the leading universities in Mexico, paid a visit to NDM’s Jenner Institute.

RECOVERY trial team wins the MRC Impact Prize

The Medical Research Council Prize Committee has awarded the RECOVERY trial team the MRC Impact Prize 2022 for Outstanding Team Impact.

Shifting the needle: finding solutions for rare diseases

Rare diseases are a global health challenge. To address this, organisations around the world, including the Nuffield Department of Medicine (NDM), are working together to find solutions for patients.

Coronavirus Vaccines Research and Development Roadmap launched

The Coronavirus Vaccines Research and Development Roadmap is a comprehensive plan to galvanize a global effort to protect the world from this large and dangerous family of viruses.

Lithuanian Ambassador visits the Ludwig Institute for Cancer Research

The Lithuanian Ambassador to the United Kingdom, His Excellency Mr Eitvydas Bajarūnas, paid a visit to Professor Skirmantas Kriaučionis of the Ludwig Institute for Cancer Research at the Nuffield Department of Medicine.

Multidisciplinary dengue forecasting project launches in Vietnam

DART (Dengue Advanced Readiness Tools), is a new project supported by Wellcome to use climate data to better predict and prepare for infectious diseases outbreaks.